What's in Innogene Kalbiotech Pte. Ltd's pipeline?

Innogene Kalbiotech Pte. Ltd has 3 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Innogene Kalbiotech Pte. Ltd's portfolio?

Top competitors by shared drug class: Arbor Pharmaceuticals, Inc., Medical University of Silesia, Seref istek, The Hospital for Sick Children, Université de Sherbrooke.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/innogene-kalbiotech-pte-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Innogene Kalbiotech Pte. Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Innogene Kalbiotech Pte. Ltd pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
6% Hydroxy Ethyl Starch	6% Hydroxy Ethyl Starch	marketed
Hypertonic lactate	Hypertonic lactate	marketed	Hypertonic solution / Metabolic support agent	Critical Care / Intensive Care Medicine
Hyperosmolar sodium lactate	Hyperosmolar sodium lactate	phase 3	Osmotic agent	Neurology

Therapeutic area mix

Critical Care / Intensive Care Medicine · 1
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Arbor Pharmaceuticals, Inc. · 1 shared drug class
Medical University of Silesia · 1 shared drug class
Seref istek · 1 shared drug class
The Hospital for Sick Children · 1 shared drug class
Université de Sherbrooke · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Innogene Kalbiotech Pte. Ltd:

Cite this brief

Drug Landscape (2026). Innogene Kalbiotech Pte. Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/innogene-kalbiotech-pte-ltd. Accessed 2026-05-17.